Structure activity relationship studies on Amb639752: toward the identification of a common pharmacophoric structure for DGKα inhibitors

References

• Cai J, Abramovici H, Gee SH, Topham MK. Diacylglycerol kinases as sources of phosphatidic acid. Biochim Biophys Acta 2009;1791:942–8.
   PubMed Web of Science ®Google Scholar
• Krishna S, Zhong X. Role of diacylglycerol kinases in T cell development and function. Crit Rev Immunol 2013;33:97–118.
   PubMed Web of Science ®Google Scholar
• Merida I, Avila-Flores A, Merino E. Diacylglycerol kinases: at the hub of cell signalling. Biochem J 2008;409:1–18.
   PubMed Web of Science ®Google Scholar
• Sakane F, Imai S, Kai M, et al. Diacylglycerol kinases: why so many of them? Biochim Biophys Acta 2007;1771:793–806.
   PubMed Web of Science ®Google Scholar
• Baldanzi G, Bettio V, Malacarne V, Graziani A. Diacylglycerol kinases: shaping diacylglycerol and phosphatidic acid gradients to control cell polarity. Front Cell Dev Biol 2016;4:140.
   PubMed Web of Science ®Google Scholar
• Tangye SG. XLP: clinical features and molecular etiology due to mutations in sh2d1a encoding sap. J Clin Immunol 2014;34:772–9.
   PubMedGoogle Scholar
• Baldanzi G, Pighini A, Bettio V, et al. Sap-mediated inhibition of diacylglycerol kinase alpha regulates TCR-induced diacylglycerol signaling. J Immunol 2011;187:5941–51.
   PubMed Web of Science ®Google Scholar
• Ruffo E, Malacarne V, Larsen SE, et al. Inhibition of diacylglycerol kinase α restores restimulation-induced cell death and reduces immunopathology in XLP-1. Sci Transl Med 2016;8:321–327.
   Web of Science ®Google Scholar
• Velnati S, Ruffo E, Massarotti A, et al. Identification of a novel DGKalpha inhibitor for XLP-1 therapy by virtual screening. Eur J Med Chem 2019;164:378–90.
   PubMed Web of Science ®Google Scholar
• Bacchiocchi R, Baldanzi G, Carbonari D, et al. Activation of alpha-diacylglycerol kinase is critical for the mitogenic properties of anaplastic lymphoma kinase. Blood 2005;106:2175–82.
   PubMed Web of Science ®Google Scholar
• Yanagisawa K, Yasuda S, Kai M, et al. Diacylglycerol kinase alpha suppresses tumor necrosis factor-alpha-induced apoptosis of human melanoma cells through NF-kappaB activation. Biochim Biophys Acta 2007;1771:462–74.
   PubMed Web of Science ®Google Scholar
• Baldanzi G, Cutrupi S, Chianale F, et al. Diacylglycerol kinase-alpha phosphorylation by Src on Y335 is required for activation, membrane recruitment and Hgf-induced cell motility. Oncogene 2008;27:942–56.
   PubMed Web of Science ®Google Scholar
• Filigheddu N, Cutrupi S, Porporato PE, et al. Diacylglycerol kinase is required for Hgf-induced invasiveness and anchorage-independent growth of mda-mb-231 breast cancer cells. Anticancer Res 2007;27:1489–92.
   PubMed Web of Science ®Google Scholar
• Rainero E, Caswell PT, Muller PA, et al. Diacylglycerol kinase alpha controls RCP-dependent integrin trafficking to promote invasive migration. J Cell Biol 2012;196:277–95.
   PubMed Web of Science ®Google Scholar
• Takeishi K, Taketomi A, Shirabe K, et al. Diacylglycerol kinase alpha enhances hepatocellular carcinoma progression by activation of Ras–Raf–MEK–ERK pathway. J Hepatol 2012;57:77–83.
   PubMed Web of Science ®Google Scholar
• Torres-Ayuso P, Daza-Martin M, Martin-Perez J, et al. Diacylglycerol kinase alpha promotes 3D cancer cell growth and limits drug sensitivity through functional interaction with Src. Oncotarget 2014;5:9710–26.
   PubMedGoogle Scholar
• Rainero E, Cianflone C, Porporato PE, et al. The diacylglycerol kinase alpha/atypical PKC/beta1 integrin pathway in SDF-1alpha mammary carcinoma invasiveness. PLoS One 2014;9:e97144.
   PubMed Web of Science ®Google Scholar
• Hao X, Sun B, Hu L, et al. Differential gene and protein expression in primary breast malignancies and their lymph node metastases as revealed by combined cDNA microarray and tissue microarray analysis. Cancer 2004;100:1110–22.
   PubMed Web of Science ®Google Scholar
• Marchet A, Mocellin S, Belluco C, et al. Gene expression profile of primary gastric cancer: towards the prediction of lymph node status. Ann Surg Oncol 2007;14:1058–64.
   PubMed Web of Science ®Google Scholar
• Dominguez CL, Floyd DH, Xiao A, et al. Diacylglycerol kinase α is a critical signaling node and novel therapeutic target in glioblastoma and other cancers. Cancer Discov 2013;3:782–97.
   PubMed Web of Science ®Google Scholar
• Kefas B, Floyd DH, Comeau L, et al. A miR-297/hypoxia/DGK-α axis regulating glioblastoma survival. Neuro Oncol 2013;15:1652–63.
   PubMed Web of Science ®Google Scholar
• Purow B. Molecular pathways: targeting diacylglycerol kinase alpha in cancer. Clin Cancer Res 2015;21:5008–12.
   PubMed Web of Science ®Google Scholar
• Jiang Y, Sakane F, Kanoh H, Walsh JP. Selectivity of the diacylglycerol kinase inhibitor 3-[2-(4-[bis-(4-fluorophenyl)methylene]-1-piperidinyl)ethyl]-2, 3-dihydro-2-thioxo-4(1h)quinazolinone (r59949) among diacylglycerol kinase subtypes. Biochem Pharmacol 2000;59:763–72.
   PubMed Web of Science ®Google Scholar
• Sato M, Liu K, Sasaki S, et al. Evaluations of the selectivities of the diacylglycerol kinase inhibitors r59022 and r59949 among diacylglycerol kinase isozymes using a new non-radioactive assay method. Pharmacology 2013;92:99–107.
   PubMed Web of Science ®Google Scholar
• Boroda S, Niccum M, Raje V, et al. Dual activities of ritanserin and r59022 as DGKα inhibitors and serotonin receptor antagonists. Biochem Pharmacol 2017;123:29–39.
   PubMed Web of Science ®Google Scholar
• Gaulton A, Hersey A, Nowotka M, et al. The ChEMBL database in 2017. Nucleic Acids Res 2017;45:D945–D954.
   PubMed Web of Science ®Google Scholar
• Leysen JE, Gommeren W, Van Gompel P, et al. Receptor-binding properties in vitro and in vivo of ritanserin: a very potent and long acting serotonin-S2 antagonist. Mol Pharmacol 1985;27:600–11.
   PubMed Web of Science ®Google Scholar
• Hawkins PC, Skillman AG, Nicholls A. Comparison of shape-matching and docking as virtual screening tools. J Med Chem 2007;50:74–82.
   PubMed Web of Science ®Google Scholar
• Muchmore SW, Souers AJ, Akritopoulou-Zanze I. The use of three-dimensional shape and electrostatic similarity searching in the identification of a melanin-concentrating hormone receptor 1 antagonist. Chem Biol Drug Des 2006;67:174–6.
   PubMed Web of Science ®Google Scholar
• Liu K, Kunii N, Sakuma M, et al. A novel diacylglycerol kinase α-selective inhibitor, CU-3, induces cancer cell apoptosis and enhances immune response. J Lipid Res 2016;57:368–79.
   PubMed Web of Science ®Google Scholar
• Baell JB, Holloway GA. New substructure filters for removal of pan assay interference compounds (pains) from screening libraries and for their exclusion in bioassays. J Med Chem 2010;53:2719–40.
   PubMed Web of Science ®Google Scholar
• Lavagno L, Gunella G, Bardelli C, et al. Anti-inflammatory drugs and tumor necrosis factor-alpha production from monocytes: role of transcription factor NF-kappa B and implication for rheumatoid arthritis therapy. Eur J Pharmacol 2004;501:199–208.
   PubMed Web of Science ®Google Scholar
• Talmon M, Rossi S, Pastore A, et al. Vortioxetine exerts anti-inflammatory and immunomodulatory effects on human monocytes/macrophages. Br J Pharmacol 2018;175:113–24.
   PubMed Web of Science ®Google Scholar
• Omega, version 2.4.6; OpenEye Scientific Software: Santa Fe, NM. Available from: http://www.eyesopen.com
   Google Scholar
• Hawkins PCD, Skillman AG, Warren GL, et al. Conformer generation with omega: algorithm and validation using high quality structures from the Protein Databank and Cambridge Structural Database. J Chem Inf Model 2010;50:572–84.
   PubMed Web of Science ®Google Scholar
• Hawkins PCD, Nicholls A. Conformer generation with omega: learning from the data set and the analysis of failures. J Chem Inf Model 2012;52:2919–36.
   PubMed Web of Science ®Google Scholar
• Schneidman-Duhovny D, Dror O, Inbar Y, et al. Pharmagist: a webserver for ligand-based pharmacophore detection. Nucleic Acids Res 2008;36:W223–228.
   PubMed Web of Science ®Google Scholar
• Wermuth C, Aldous D, Raboisson P, Rognan D. The practice of medicinal chemistry. 4th ed. London, UK: Academic Press; 2015.
   Google Scholar
• Johansson H, Urruticoechea A, Larsen I, Sejer Pedersen D. A scalable method for regioselective 3-acylation of 2-substituted indoles under basic conditions. J Org Chem 2015;80:471–81.
   PubMed Web of Science ®Google Scholar
• Sakane F, Mizuno S, Komenoi S. Diacylglycerol kinases as emerging potential drug targets for a variety of diseases: an update. Front Cell Dev Biol 2016;4:82.
   PubMed Web of Science ®Google Scholar
• Franks CE, Campbell ST, Purow BW, et al. The ligand binding landscape of diacylglycerol kinases. Cell Chem Biol 2017;24:870–80.e5.
   PubMed Web of Science ®Google Scholar
• Joshi RP, Schmidt AM, Das J, et al. The ζ isoform of diacylglycerol kinase plays a predominant role in regulatory T cell development and TCR-mediated ras signaling. Sci Signal 2013;6:ra102.
   PubMed Web of Science ®Google Scholar
• Tu-Sekine B, Goldschmidt HL, Raben DM. DGK-θ: structure, enzymology, and physiological roles. Front Cell Dev Biol 2016;4:101.
   PubMed Web of Science ®Google Scholar